Daniel Markowitz
Stock Analyst at Evercore ISI Group
(1.98)
# 3,153
Out of 5,241 analysts
42
Total ratings
41.94%
Success rate
-5.9%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $250 → $270 | $186.36 | +44.88% | 4 | May 8, 2026 | |
| GH Guardant Health | Maintains: In-Line | $90 → $95 | $94.92 | +0.08% | 6 | May 8, 2026 | |
| TECH Bio-Techne | Maintains: In-Line | $54 → $50 | $43.30 | +15.47% | 6 | May 7, 2026 | |
| PODD Insulet | Maintains: Outperform | $240 → $200 | $147.46 | +35.63% | 3 | May 7, 2026 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $62 → $55 | $40.05 | +37.33% | 4 | May 5, 2026 | |
| RMBS Rambus | Maintains: Outperform | $119 → $172 | $127.05 | +35.38% | 4 | Apr 28, 2026 | |
| RGEN Repligen | Maintains: Outperform | $170 → $140 | $102.87 | +36.09% | 6 | Apr 6, 2026 | |
| TMDX TransMedics Group | Maintains: Outperform | $170 → $118 | $63.20 | +86.71% | 3 | Apr 6, 2026 | |
| MMED MiniMed Group | Initiates: Outperform | $20 | $10.80 | +85.19% | 1 | Mar 31, 2026 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $390 → $320 | $302.89 | +5.65% | 4 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: In-Line | $68 | $61.63 | +10.34% | 1 | Nov 25, 2025 |
Natera
May 8, 2026
Maintains: Outperform
Price Target: $250 → $270
Current: $186.36
Upside: +44.88%
Guardant Health
May 8, 2026
Maintains: In-Line
Price Target: $90 → $95
Current: $94.92
Upside: +0.08%
Bio-Techne
May 7, 2026
Maintains: In-Line
Price Target: $54 → $50
Current: $43.30
Upside: +15.47%
Insulet
May 7, 2026
Maintains: Outperform
Price Target: $240 → $200
Current: $147.46
Upside: +35.63%
Inspire Medical Systems
May 5, 2026
Maintains: Outperform
Price Target: $62 → $55
Current: $40.05
Upside: +37.33%
Rambus
Apr 28, 2026
Maintains: Outperform
Price Target: $119 → $172
Current: $127.05
Upside: +35.38%
Repligen
Apr 6, 2026
Maintains: Outperform
Price Target: $170 → $140
Current: $102.87
Upside: +36.09%
TransMedics Group
Apr 6, 2026
Maintains: Outperform
Price Target: $170 → $118
Current: $63.20
Upside: +86.71%
MiniMed Group
Mar 31, 2026
Initiates: Outperform
Price Target: $20
Current: $10.80
Upside: +85.19%
West Pharmaceutical Services
Feb 3, 2026
Maintains: Outperform
Price Target: $390 → $320
Current: $302.89
Upside: +5.65%
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $61.63
Upside: +10.34%